Efficacy of vitamin A in the prevention of locoregional recurrence and second primaries in head and neck cancer

European Journal of Cancer Part B: Oral Oncology

Volumn 32, Issue 6, 1996, Pages 373-376

  Jyothirmayi, R ^a   Ramadas, K ^a   Varghese, C ^a   Jacob, R ^a   Nair, M K ^a   Sankaranarayanan, R ^b  

^a REGIONAL CANCER CENTRE   (India)

^b INTERNATIONAL AGENCY FOR RESEARCH ON CANCER   (France)

Author keywords

Chemoprevention; Head and neck cancer; Local recurrence; Oral cancer; Prevention; Second primaries; Vitamin A

Indexed keywords

PLACEBO; RETINOID; RETINOL; RETINOL PALMITATE;

ADULT; AGED; ARTICLE; CANCER RECURRENCE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HEAD AND NECK CANCER; HUMAN; MAJOR CLINICAL STUDY; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SECOND CANCER;

ANTICARCINOGENIC AGENTS; FEMALE; FOLLOW-UP STUDIES; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; NEOPLASMS, SECOND PRIMARY; VITAMIN A;

EID: 0030292317     PISSN: 09641955     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0964-1955(96)00010-3     Document Type: Article

References (25)

1. 1. ICMR. National Cancer Registry Programme. Biennial Report 1988-1989. New Delhi, Indian Council of Medical Research, 1092.
2. 2. Sankaranarayanan R, Duffy SW, Padmakumari G, Day NE, Padmanabhan TK. Tobacco chewing, alcohol and nasal snuff in cancer m the gingiva in Kerala, India. Br J Cancer 1989, 60., 638-643.
3. 3. Sankaranarayanan R, Duffy SW, Day NE, Krishnan Nair M, Padmakumary G. A case control investigation of cancer of the oral tongue and the floor of the mouth in southern India. Int J Cancer 1989, 44, 617-621.
4. 4. Sankaranarayanan R, Duffy SW, Krishnan Nair M, Padmakumary G, Day NE, Tobacco and alcohol as risk factors in cancer of the larynx in Kerala, India. Int J Cancer 1990, 45, 879-882.
5. 5. Sankaranarayanan R, Duffy SW, Padmakumary G, Day NE, Krishnan Nair M. Risk factors for cancer of the buccal and labial mucosa in Kerala, India. J Epidemiol Comm Health 1990, 44, 286-292.
6. 6. Krishnan Nair M. Sankaranarayanan R. Padmanabhan TK. Evaluation of the role of radiotherapy in the management of carcinoma of the buccal mucosa. Cancer 1988, 61, 1326-1331.
7. 7. Padmanabhan TK, Sankaranarayanan R, Krishnan Nair M. Evaluation of local control, survival and pattern of failure with radiotherapy in cancer of the oral tongue. Oncology 1990, 47, 121-123.
8. 8. Krishnan Nair M, Sankaranarayanan R, Krishnan E, Padmanabhan TK, Mayadevi S. Aleyamma M. Independent predictors of response and disease free survival in oral cancer treated with radical radiotherapy. Cancer 1992, 69, 2221-2227.
9. 9. Haughey BH, Gates GA, Arfken CL, Harvey J. Meta-analysis of second malignant tumours in head and neck cancer: the case for an endoscopic screening protocol. Ann Otol Rhin Laryngol 1992, 101, 105-112.
10. 10. Day GL, Blot WJ. Second primary tumours in patients with oral cancer. Cancer 1992, 70, 14-19.
11. 11. Sankaranarayanan R, Mathew B, Nair PP, et al. Chemoprevention of the cancers of the oral cavity and head and neck. In: Hakama M, Beral V, Buiatti E, Faivre J, Parkin DM, Eds. Chemoprevention in Cancer Control. IARC Scientific Publications No. 136. Lyon, IARC, 1996, 13-25.
12. 12. Tanaka T. Chemoprevention of oral carcinogenesis. Oral Oncol, Eur J Cancer 1995, 31B, 3-15.
13. 13. Scully C. Oral precancer: preventive and medical approaches to management. Oral Oncol, Eur J Cancer 1995, 31B, 16-26.
14. 14. Bolla M, Lefur R, Ton Van C, et al. Prevention of second primary tumours with etretinate in squamous cell carcinoma of the oral cavity and oropharynx. Results of a multicentric double blind randomised study. Eur J Cancer 1994, 30A, 767-772.
15. 15. Benner SE, Pajak TF, Lippman SM, Earley C, Hong WK. Prevention of second primary tumours with isotretmoin in patients with squamous cell carcinoma of the head and neck: long term follow-up. J Natl Cancer Inst 1994, 86, 140-141.
16. 16. Pastorino U, Infante M, Maiola M. Adjuvant treatment of stage I lung cancer with high dose vitamin A. J Clin Oncol 1993, 11, 1216-1222.
17. 17. Vries N de, Pastorino U, Zandwijk N van. Chemoprevention of second primary tumours in head and neck cancer in Europe: EUROSCAN. Oral Oncol, Eur J Cancer 1994, 30B, 367-368.
18. 18. Lippman SM, Benner SE, Hong WK. Retmoid chemoprevention studies in upper aerodigestive tract and lung carcinogenesis. Cancer Res 1994, 54 (Suppl.), 205s-208s.
19. 19. Stich HF, Hornby AP, Mathew B, Sankaranarayanan R, Krishnan Nair M. Response of oral leukoplakias to the administration of vitamin A. Cancer Lett 1988, 40, 93-101.
20. 20. Sankaranarayanan R, Mathew B, Varghese C, et al. Chemoprevention of oral leukoplakia with vitamin A and beta carotene: an assessment. Oral Oncol, Eur J Cancer (to appear).
21. 21. Hong WK, Endicott J. Itri LM, et al. 13-cis retinoic acid in the treatment of oral leukoplakia. N Engl J Med 1986, 315, 1501-1505.
22. 22. Lippman SM, Batsakis JG, Toth BB, et al. Comparison of low-dose isotretinoin with beta-carotene to prevent oral carcinogenesis. N Engl J Med 1993, 328, 15-20.
23. 23. Pastorino U, Chisea G, Infante M, et al. Safety of high-dose vitamin A. Oncology 1991, 48, 131-137.
24. 24. Omenn GS, Goodman GE, Thornquist M., et al. The B-carotene and retinol efficacy trial (CARET) for chemoprevention of lung cancer in high risk populations: smokers and asbestos exposed workers. Cancer Res 1994, 54, 2038s-2043s.
25. 25. Omenn GS, Goodman GE, Thornquist M, et al. Long term vitamin A does not produce clinically significant hypertriglyceridaemia: Results from CARET, the B-carotene and retinol efficacy trial. Cancer Epidemiol Biomarkers Prevention 1994, 3, 711-713.